HEPA
Price
$0.29
Change
-$0.00 (-0.00%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
3.16M
KTTA
Price
$1.74
Change
+$0.01 (+0.58%)
Updated
Apr 28, 02:20 PM (EDT)
Capitalization
4.68M
Ad is loading...

HEPA vs KTTA

Header iconHEPA vs KTTA Comparison
Open Charts HEPA vs KTTABanner chart's image
Hepion Pharmaceuticals
Price$0.29
Change-$0.00 (-0.00%)
Volume$100
Capitalization3.16M
Pasithea Therapeutics
Price$1.74
Change+$0.01 (+0.58%)
Volume$459
Capitalization4.68M
HEPA vs KTTA Comparison Chart
Loading...
HEPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HEPA vs. KTTA commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HEPA is a Hold and KTTA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (HEPA: $0.29 vs. KTTA: $1.73)
Brand notoriety: HEPA and KTTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HEPA: 11% vs. KTTA: 7%
Market capitalization -- HEPA: $3.16M vs. KTTA: $4.68M
HEPA [@Biotechnology] is valued at $3.16M. KTTA’s [@Biotechnology] market capitalization is $4.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HEPA’s FA Score shows that 0 FA rating(s) are green whileKTTA’s FA Score has 0 green FA rating(s).

  • HEPA’s FA Score: 0 green, 5 red.
  • KTTA’s FA Score: 0 green, 5 red.
According to our system of comparison, KTTA is a better buy in the long-term than HEPA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HEPA’s TA Score shows that 3 TA indicator(s) are bullish while KTTA’s TA Score has 6 bullish TA indicator(s).

  • HEPA’s TA Score: 3 bullish, 2 bearish.
  • KTTA’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, KTTA is a better buy in the short-term than HEPA.

Price Growth

HEPA (@Biotechnology) experienced а -10.74% price change this week, while KTTA (@Biotechnology) price change was +25.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.19%. For the same industry, the average monthly price growth was +1.10%, and the average quarterly price growth was -9.09%.

Reported Earning Dates

HEPA is expected to report earnings on Apr 08, 2025.

KTTA is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (+11.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KTTA($4.68M) has a higher market cap than HEPA($3.16M). KTTA YTD gains are higher at: -45.079 vs. HEPA (-98.777). KTTA has higher annual earnings (EBITDA): -15.49M vs. HEPA (-29.39M). KTTA has more cash in the bank: 9.36M vs. HEPA (1.5M). KTTA has less debt than HEPA: KTTA (0) vs HEPA (2.22M). HEPA (0) and KTTA (0) have equivalent revenues.
HEPAKTTAHEPA / KTTA
Capitalization3.16M4.68M67%
EBITDA-29.39M-15.49M190%
Gain YTD-98.777-45.079219%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.5M9.36M16%
Total Debt2.22M0-
FUNDAMENTALS RATINGS
HEPA: Fundamental Ratings
HEPA
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HEPAKTTA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bullish Trend 6 days ago
73%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
HEPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKBA2.380.10
+4.39%
Akebia Therapeutics
CRDL1.080.01
+0.93%
Cardiol Therapeutics
SONN1.370.01
+0.74%
Sonnet BioTherapeutics Holdings Inc
SPB62.710.43
+0.69%
Spectrum Brands Holdings
MEDP298.55-4.33
-1.43%
Medpace Holdings

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and FATE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
+0.58%
FATE - KTTA
32%
Poorly correlated
-5.19%
ACET - KTTA
25%
Poorly correlated
-4.62%
SPRB - KTTA
24%
Poorly correlated
-7.22%
TRAW - KTTA
24%
Poorly correlated
+1.31%
HEPA - KTTA
24%
Poorly correlated
-0.86%
More